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Adams 1 
Conflict and Vaccine-Preventable Disease in Children under Five in the  
Eastern Mediterranean Region: A Systematic Review 
 
Background: Conflict is one of the main reasons for our failure to reach worldwide 
immunization targets. An objective of 90% immunization coverage is included in the fourth 
Millennium Development Goal to reduce under-five mortality by two thirds, which is still far 
from achieved in the conflict-ridden Eastern Mediterranean Region (EMR). Despite global 
progress, vaccine-preventable deaths still account for 20% of childhood mortality under five 
years of age in the EMR, and communicable disease a third of all mortality. Conflict remains a 
critical root cause of low vaccination coverage in the EMR, resulting in high levels of vaccine-
preventable disease, disability, and death.  
 
Research Question: The aim of this review is to assess the impact of conflict on vaccine-
preventable disease vaccination coverage and outcomes in children under five in the Eastern 
Mediterranean Region. While international attention is drawn to outbreaks of polio and measles, 
several other easily avoidable infections are also responsible for high rates of morbidity and 
mortality, especially in children. This review will give a more holistic view on the burden of 
vaccine-preventable disease associated with conflict, as well as identify gaps in our current 
knowledge and explore common factors in prevention of immunization uptake.  
 
Methods: This systematic review was performed using the PRISMA guidelines. Search terms 
related to conflict, the EMR, vaccines in the WHO Expanded Programme for Immunization 
(EPI) package, and children were entered into MEDLINE, Embase, Global Health, and 
Cochrane. Eighty seven unique articles were identified, and after an abstract and full text review 
and a forward search, 26 were retained for data extraction and analysis. 
 
Results: Results were distributed between four different countries of origin (Afghanistan, 
Pakistan, Somalia, and Sudan), five different countries of study (Afghanistan, Pakistan, Sudan, 
Somalia, and Kenya), and six out of ten diseases in the EPI (poliovirus, measles, hepatitis B, 
tetanus, diphtheria, and pertussis). The majority of results addressed poliovirus (n=16) and 
measles (n=9). Outcomes, vaccination coverage, and barriers to vaccination was analyzed 
according to disease. 
 
Conclusions: There is a large gap of knowledge regarding vaccine-preventable diseases in 
children under five in conflict-affected areas of the Eastern Mediterranean Region. 
Understanding the prevalence, mortality, and barriers to vaccination involved in these 
challenging environments will help us reach the WHO goals of 90% vaccination coverage and 
reduce worldwide childhood mortality. 
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Introduction 
 
Conflict and infectious disease come hand in hand, as we are recently reminded by outbreaks of 
polio, measles, typhoid, and hepatitis A in the growing Syrian refugee camps. Three years of 
civil conflict has led to the death of 125,000 and the displacement of over 2.7 million (UNHCR 
2014). Polio has reemerged after 14 years of elimination due to the breakdown of health systems 
and lack of sanitation, and 80% of excess deaths can be attributed to communicable disease. 
Unfortunately, many these deaths were easily preventable – immunization coverage was as low 
as 60% across Syria in 2012, leaving the population increasingly vulnerable to outbreaks (Coutts 
& Fouad, 2014). This situation is not uncommon in the Eastern Mediterranean Region (EMR). 
 In the 20th century, between 191 and 231 million people died as a direct or indirect result 
of conflict, with civilian greatly outnumbering combatant deaths (Otterson et al., 2014). In 2013 
alone, the UNHCR estimated 38.7 million people of concern throughout the world, including 
refugees and internally displaced people 
(UNHCR, 2013).  
 The EMR is particularly conflict-
ridden, beyond Syria’s ongoing conflict 
(see Table 1). Since 1975, 18 out of 21 
countries in the region have experienced 
some sort of organized conflict (Uppsala, 
2013). Conflict-related mortality 
increasingly shifts towards the civilian 
population, and civilian death accounts for 
90% of conflict-related mortality in the 21st century (Okonko et al., 2009). Specifically in the 
EMR, hundreds of thousands of civilian deaths are estimated in the last decade in Afghanistan, 
Iraq, and Syria alone, and 10.8 million refugees and IDPs have resulted from conflicts solely in 
Afghanistan, Pakistan, Sudan, and Syria (Otterson et al., 2014; UNHCR, 2013). Mortality is 
highest among children under five years of age largely due to the disruption of normal childhood 
health services, resulting in high rates of diarrheal diseases, acute respiratory infections, measles, 
malaria, and severe malnutrition, followed by outbreaks of other communicable diseases such as 
pertussis and meningococcal meningitis (Zwi, 2006; Toole & Waldman, 1997). A large portion 
of these deaths are easily preventable with vaccination. Causes of death have not changed 
significantly since the change of the century, emphasizing the necessity of increasing uptake of 
vaccination in conflict-affected areas (Moss et al., 2006).  
 The implications of conflict reach beyond violence-related death and disability to the 
destruction of infrastructure, food shortages, and the mass displacement of people, creating an 
ideal environment for the spread of infectious disease (Toole & Waldman, 1997). In recent 
conflicts in Iraq and Syria, healthcare services have been directly targeted, forcing physicians to 
flee and hospitals to be deserted (Otterson et al., 2014). These conflicts disrupt the delivery of 
essential interventions such as vaccinations, in addition to making populations more vulnerable 
to infectious diseases and interrupting surveillance and response programs (Okonko et al., 2009). 
Vaccination is a highly cost effective intervention, as available care post-infection is limited, 
with an estimated total of $162 per capita spent on healthcare in the EMR, compared to the 
global average of $845 in 2009, and even less in conflict-areas of the EMR (Haq et al., 2013). In 
these low-income settings, vaccination is an essential, cost-effective intervention needed to 
prevent excess mortality. 
Table 1. Countries in the Eastern Mediterranean Region 
(EMR), as defined by the World Health Organization 
 
Afghanistan 
Bahrain 
Dijbouti 
Egypt 
Iran 
Iraq 
Jordan* 
Kuwait 
Lebanon 
Libya 
Morocco 
Oman 
Pakistan 
Qatar* 
Saudi Arabia 
Somalia 
Sudan 
Syrian Arab Republic 
Tunisia 
United Arab Emirates* 
Yemen 
 
*has not experienced a conflict since 1975 (Uppsala, 2013) 
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Conflict and vaccine-preventable disease 
 
Conflict is known to be one of the main reasons for our failure to reach worldwide immunization 
targets (Haq et al., 2013). An objective of 90% immunization coverage is included in the fourth 
Millennium Development Goal, to reduce under-five mortality by two thirds, which is still far 
from achieved in the conflict-ridden EMR.  
 Vaccination efforts in the EMR began in 1974 with the founding of the Expanded 
Programme on Immunization (EPI) by the WHO. EPI was created to expand access to 
vaccination to children and women in developing countries, at a time when less than 5% of 
children worldwide were receiving vaccinations in the first year of life. At the time, the 
“traditional” package included four vaccinations (BCG, DPT, OPV, and measles) for six 
diseases: tuberculosis, diphtheria, pertussis, tetanus, poliomyelitis, and measles (UNICEF, 2011). 
The EPI was progressively adopted by all countries, and was universal by the early 1980s 
(Mansoor, 2008). 
 By 2013, global coverage of these four vaccinations reached 83%, and the EPI vaccination 
package now includes eight vaccinations targeting a total of ten diseases (listed in Table 2) 
(UNICEF, 2011). Yellow fever vaccine was added to the package in 1988 for affected countries 
in Africa and South America; yellow fever is recommended for Sudan and Somalia, so it was 
included in this systematic review (Gershman & Staples, 2013). Hepatitis B vaccine was added 
in 1992 for high burden countries and expanded to all countries by 1997. Haemophilus 
influenzae type B (Hib) was added to the list for high burden countries in 1998 and extended to 
all countries by 2006. Possible vaccinations being considered as future additions to the EPI 
package may include pneumococcal conjugate vaccine (PCV), rotavirus vaccine, human 
papillomavirus vaccine (HPV), and regionally specific vaccines including typhoid, Japanese 
encephalitis, and meningitis (Mansoor, 2008). 
 The EPI has since developed the Global Vaccine Action Plan (GVAP), which aims to 
eliminate polio and prevent 24-26 million deaths through the expanded vaccination package by 
2020 (WHO 2013, GVAP, 2013). One of the elements of GVAP’s Strategy is to research the 
best delivery approaches for humanitarian emergencies, fragile states, and countries in or 
emerging from conflict (GVAP, 2013). 
 Despite this global progress, vaccine-preventable deaths still account for 20% of childhood 
mortality under five years of age in the EMR (WHO-EM, 2011), and communicable disease a 
third of all mortality in the region (Haq et al., 2013). Weak health systems, insufficient 
government financial allocations, low community awareness and trust of services, regional 
instability, and lack of coordination between humanitarian and health care workers hinders the 
effective delivery of health services such as 
vaccination (Haq et al., 2013; Okonko et al., 
2009). Conflict remains a critical root cause 
of low vaccination coverage in the EMR, 
resulting in high levels of vaccine-
preventable disease, disability, and death. 
 
Prevention and response 
 
Prevention of these vaccine-preventable diseases is difficult to navigate in conflict settings. 
Adequate food, shelter, water, sanitation and immunization are difficult to achieve in war-
Table 2. Vaccine-preventable diseases included in the 
Expanded Programme for Immunization (EPI) 
 
Diphtheria 
Hepatitis B 
Haemophilus Influenzae type B 
Measles 
Pertussis (whooping cough) 
Poliomyelitis 
Rubella 
Tetanus 
Tuberculosis 
Yellow Fever 
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affected countries. Early warning systems, surveillance, and emergency preparedness planning 
are critical to establish before situations become unmanageable, with a foundation of standard 
public health policies, treatment protocols, staff training, and the maintenance of reserves of 
essential drugs and vaccines for use in emergencies (Toole, 1997). Rapid assessments are often 
overlooked, when the early identification of the most vulnerable sub-populations could save 
many lives. Initially channeling resources towards addressing measles, diarrheal disease, 
malnutrition, and acute respiratory infections among women and children is know to be a cost 
effective approach to preventing excess mortality. Immunizing children between 6 months and 5 
years of age is known to be the single most important and cost-effective intervention in 
emergency-affected populations, which should then be followed by the other vaccines in the EPI 
package (Haq et al., 2013).  
 The current guidelines for prevention of vaccine-preventable disease in the Sphere Project 
Minimum Standards in Humanitarian Response call for an immediate estimation of measles 
vaccination coverage in children aged 9 months to 15 years to prevent future outbreaks. If 
vaccination coverage is below 90%, a vaccination campaign should be launched for children 
aged 6 months to 15 years, including Vitamin A administration, and coverage should be 
maintained above 95% for any mobile or displaced populations as newcomers come to the camp. 
Measles vaccination should then be followed with the rest of the EPI package as soon as the 
situation has somewhat stabilized (Sphere Handbook, 2011).  
 
Research questions  
 
The aim of this systematic review is to assess the impact of conflict on vaccine-preventable 
disease outcomes in the Eastern Mediterranean Region. While international attention is drawn to 
outbreaks of polio and measles, a long list of other easily avoidable infections is responsible for 
high rates of morbidity and mortality, especially in children. This review will give a more 
holistic view on the burden of vaccine-preventable disease associated with conflict, as well as 
identify gaps in our current knowledge and explore common factors in prevention of 
immunization uptake. Until these factors are better understood and addressed, achievement of the 
MDGs will continue to fall short. 
 
Methods 
 
Literature was reviewed based on the preferred reporting items for systematic review and meta-
analysis (PRISMA) guidelines.  
 
Search strategy for identification of studies 
 
Searches were conducted in the databases MEDLINE, Embase, Global Health, and Cochrane 
Library, and all searches were limited to the English language and from 1974 (the year that EPI 
was established) to the February 2014 search date. Search criteria included a combination of one 
or more conflict-related terms, one or more vaccine-preventable disease-related terms, and all 
countries included in the WHO-defined Eastern Mediterranean Region. It should be noted that 
the EMR differs from the World Bank-defined Middle East and North Africa (MENA) Region 
by a few countries (EMR does not contain MENA countries Algeria, Israel, Malta or West Bank 
& Gaza, but does contain Afghanistan, Pakistan, Somalia, and Sudan) (WHO, 2014; World 
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Bank, 2013). Conflict-related keywords included “refugees,” “internally displaced,” “displaced 
persons,” “conflict affected,” “post conflict,” “war,” and “terrorism.” Search terms for vaccine-
preventable diseases included “diphtheria,” “hepatitis B,” “haemophilus influenza type B”, 
“measles,” “whooping cough,” “poliomyelitis,” “rubella,” “tetanus,” and “pertussis.” Child-
related terms included “child” and “infant.” See appendix Table A1 for the full search strategy. 
 Search terms related to conflict were based on those used in systematic reviews by Jack et 
al. (2013) and Roberts & Browne (2010). Child-related search terms were based on those used in 
the systematic review about child mental health in conflict by Jordans et al (2009). Vaccine-
preventable disease terms were taken from the included vaccines in the EPI package (Mansoor, 
2008). Countries included in the search terms included all of those in the World Health 
Organization list of countries in the Eastern Mediterranean Region (WHO, 2014).  
 
Study selection 
 
When screening the search results, articles that did not address populations within the Eastern 
Mediterranean Region and one of the pre-specified vaccine-preventable diseases were omitted. 
In addition, editorials and commentaries were excluded. Studies addressing refugees who were 
relocated to high-income countries were excluded due to their differing circumstances compared 
to those still living in low- and middle-income countries. Beyond these initial criteria, articles 
were evaluated by comparing them to the main components of our study question: 
 
1. Is the article specifically focused on children under five in a conflict-affected 
population? 
2. Is the article examining risk factors or outcomes of mortality, incidence, and/or 
prevalence of vaccine-preventable diseases? 
 
The database searches yielded 87 unique results after removing duplicates (see Figure 1 for 
selection process). The abstracts of this initial sample were screened by a single reviewer, 
resulting in the exclusion of 39 articles. The most common reasons for exclusion included a 
focus on refugees relocated a high-income country (n= 17) or an editorial or commentary (n=10).  
 Forty-eight articles were retained for full text review. Articles were excluded if they were a 
commentary, editorial, or letter to the editor, did not include an outcome relevant to the study 
question, a conflict-related term did not appear in the full text, the population didn’t include 
children under five, or the full text was not available. 
 At the conclusion of full text screening, a total of 16 articles were retained for data 
extraction and analysis. A forward search was performed on the references of these 16 articles, 
and 61 articles were identified to be of potential interest to the research question based off of 
their titles. After screening these 61 articles, 10 were added to the final sample, 14 were 
identified as grey literature, and 37 were excluded based on the criteria used in the full text 
screening. The grey literature was not included in final data extraction and analysis. 
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Figure 1. 
Systematic Literature Review Process !
Electronic Database Search 
(n= 87 unique articles after removing duplicates) 
 
Gross number of articles identified in each database: 
 MEDLINE: 52    Global Health: 31 
Embase: 58   Cochrane Library: 0 
Articles excluded based on abstract review 
(n= 39) 
 
Reasons for exclusion: 
• Focus on refugees relocated to high-income countries (n= 17) 
• Editorial or commentary (n= 10) 
• Study population did not originate within EMR (n= 4) 
• Not about vaccine-preventable diseases (n= 3) 
• Unrelated (n= 3)  
• Pre-1974 (n=1) 
• Evaluation of vaccine efficacy (n=1) 
Articles excluded based on full text review 
(n= 32) 
 
Reasons for exclusion: 
• Editorial, commentary, or letter to editor (n= 10) 
• Population did not include children <5 years (n= 5) 
• Did not include outcome relevant to study question (n= 5) 
• Poster presentation or conference abstract (n= 4) 
• Age group for children was not specified <5 years (n=4) 
• Conflict-related term not mentioned in full text (n= 2) 
• No full text available (n= 1) 
• Policy recommendations (n= 1) 
Abstract Review 
(n= 87) 
Full Text Screening 
(n= 48) 
Retained for Analysis 
(n= 16) 
Forward Search 
(n= 61 unique articles of interest identified from references) 
 
Identified: 
• Articles to be included in analysis (n= 10) 
• Grey literature (n= 14; not included in final analysis) 
Reasons for exclusion: 
• Conflict-related term not mentioned (n= 11) 
• Did not include outcome relevant to study question (n= 7) 
• No full text available (n= 7) 
• Not EMR-specific (n= 5) 
• Population did not include children <5 years (n= 3) 
• Editorial, commentary, or letter to editor (n= 2) 
• Low quality (n= 2) 
Final Sample 
(n= 26) 
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Results 
 
A total of 26 articles were retained in the final sample. Of these, 17 studies were Morbidity and 
Mortality Weekly Reports (MMWRs) or Weekly Epidemiological Records (WERs) from the 
CDC. Despite the inclusion criteria of studies published since 1974, publication years ranged 
only from 1987 to 2014, with an average year of 2005. A full list of results and some basic 
characteristics are included in the appendix in Table A2. 
 
Types of Participants 
 
Studies were included in the final sample if the participants were five years of age or younger 
and were living in or recently displaced from a country in the Eastern Mediterranean Region. 
Studies that defined children as <15 or <10, with no further breakdown to <5, were excluded. 
Participants originating within the EMR and relocated to a low or middle income country were 
included, but participants relocated to a high income country were excluded. Only one article 
(Polonsky, 2013) addressed populations that originated within the EMR and relocated outside to 
another low income country, Kenya. Studies were not included unless they mentioned conflict, 
but the Uppsala Conflict Database was also used to cross-verify that the countries of participant’s 
origin and/or study were conflict affected. 
 
Location 
 
Studies took place in Afghanistan, Pakistan, Somalia, Sudan, and Kenya. The participants’ 
countries of origin included Afghanistan, Pakistan, Somalia, and Sudan. Populations studied 
Kenya originated in Somalia. Several studies in Pakistan also studied populations originating in 
Afghanistan. The majority of articles focused on populations originating in either Afghanistan or 
Pakistan. See Table 2 to see the full list of countries of origin and countries of study for the 
articles included in the final sample. 
 
Table 2. Results by Country of Origin and Study 
 Origin   Study  Origin   Study  Origin   Study 
Afghanistan 
Bahrain 
Dijbouti 
Egypt 
Iran 
Iraq 
Jordan 
16 
- 
- 
- 
- 
- 
- 
14 
- 
- 
- 
- 
- 
- 
Kuwait 
Lebanon 
Libya 
Morocco 
Oman 
Pakistan 
Qatar 
- 
- 
- 
- 
- 
13 
- 
- 
- 
- 
- 
- 
15 
- 
Saudi Arabia 
Somalia 
Sudan 
Syrian Arab Republic 
Tunisia 
United Arab Emirates 
Yemen 
Kenya* 
- 
5 
2 
- 
- 
- 
- 
- 
- 
4 
3 
- 
- 
- 
- 
1 
*Note: Kenya is not in the EMR, but the population studied originated from Somalia, a country in the EMR, so it 
was included in this study. 
 
 
 
 
 
Adams 8 
Vaccine-preventable diseases 
 
Out of the 10 vaccine-
preventable diseases included in 
the EPI and included in this 
systematic review, only 6 were 
addressed in the final sample of 
articles. The majority of studies 
focused on poliomyelitis or 
measles, while only a few results addressed hepatitis B, tetanus, diphtheria, and whooping cough. 
Four EPI-included diseases were not found in the results, including Haemophilus influenza type 
B, rubella, tuberculosis, and yellow fever. A full list of results by vaccine-preventable disease is 
contained in Table 3. See Table 4 for a matrix of results comparing vaccine-preventable disease 
to population’s country of origin. 
 
 
Table 4. Matrix of Results Comparing Country of Origin to Vaccine-Preventable Disease 
 
 Diphtheria Hepatitis B Measles Pertussis Poliovirus Tetanus 
Afghanistan  1 3  12 1 
Pakistan     13  
Somalia 1  5 1  1 
Sudan   1  1  
 
Poliomyelitis 
 
Sixteen results addressed poliomyelitis in countries of the EMR. Of these 16 results, only one 
was not a CDC MMWR or WER report. In addition, while each of these results was unique, five 
pairs of reports presented the same annual data for cases and vaccination coverage for 
Afghanistan and Pakistan.! 
 Only one result did not include Afghanistan and/or Pakistan, instead focusing on polio in 
Sudan (MMWR, 2001). One result also gave an EMR-wide update (MMWR, 2000). Several of 
the worldwide CDC updates did include numbers for other countries in the EMR (such as Egypt 
and Sudan) but focused primarily on Afghanistan and Pakistan (MMWR, 2008; MMWR, 2009; 
MMWR, 2010). Poliovirus remained endemic only in Afghanistan, Pakistan, and Nigeria by 
2012, explaining the lack of results for other countries in the EMR. Poliovirus-specific results are 
documented in the appendix Table A3, with extraction of the number of cases and immunization 
coverage for each article in the final sample. 
 The number of confirmed WPV cases widely fluctuates in Afghanistan and Pakistan since 
the first result in 1997 (see Figure 2). Poliovirus is not considered endemic in Sudan, and 
transmission has been interrupted since 2009 (GPEI, 2010). No WPV3 cases have been reported 
in Afghanistan since April 2010, and WPV3 persists in small numbers in Pakistan (MMWR, 
2013). WPV2 was eliminated in 1999. In 1999, six countries reported indigenous strains of 
poliovirus: Afghanistan, Egypt, Iraq, Pakistan, Sudan, and Somalia (CDC MMWR, 1999). In the 
most recent report, only Afghanistan and Pakistan still had reportable cases (CDC MMWR, 
2013), although the recent Syrian refugee outbreak will likely increase incidence in other EMR 
countries as well. 
Table 3. Results by Vaccine-Preventable Disease 
Diphtheria 
Hepatitis B 
Haemophilus Influenzae type B 
Measles 
Pertussis (whooping cough) 
1 
1 
- 
9 
1 
Poliomyelitis 
Rubella 
Tetanus 
Tuberculosis 
Yellow Fever 
16 
- 
2 
- 
- 
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 Vaccination coverage increased from the least to most recent articles included in both 
Afghanistan and Pakistan. Vaccination coverage was defined as three doses of oral polio vaccine 
(OPV) in children less than one year old. In Afghanistan, the earliest article reported less than 
30% OPV coverage in 1996 (CDC WER, 1999), whereas the latest article reported coverage of 
66% in 2011 (CDC MMWR, 2013). This coverage fluctuated, reaching as high as 85% coverage 
in 2009 (see Figure 3 for reported OPV coverage in Afghanistan and Pakistan) (CDC MMWR, 
2010). Pakistan typically reported higher vaccination coverage than Afghanistan, but these data 
were not reliable until recently and were most likely gross overestimations, especially when 
considering the limited AFP surveillance data available (CDC MMWR, 2009). In addition, 
Sudan reported routine OPV coverage of 90%, with some regional variation (CDC MMWR, 
2001). 
 
 Regional differences in coverage were large in both countries. Provinces along the insecure 
common border had the lowest immunization coverage throughout the years. In 2009, a range of 
5 to >20% of children under five years in certain regions were inaccessible for vaccination due to 
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security issues in Afghanistan, and a range of 10 to 30% of children in Pakistan (CDC MMWR, 
2010). In Afghanistan in 2010, 84% of cases came from the conflict-affected south region, and 
69% of cases in Pakistan came from conflict-affected Federally Administered Tribal Areas 
(FATA) and Kyber-Pakhtoonkhwa Province (CDC MMWR, 2011). Every article in the 
poliovirus sample subgroup described wide regional variation within the affected countries, 
based on conflict and logistical access issues. 
 Supplementary immunization activities (SIAs) were common interventions used in 
Afghanistan, Pakistan, Sudan, as well as other non-endemic countries to reach high-risk endemic 
areas and migrant populations, trying to reach chronically missed children (CDC MMWR, 
2012). National immunization days (NIDs) were also a common SIA referred to in every article, 
which were mass campaigns that occurred over a short period of time, administering two OPV 
doses to children under five years (CDC MMWR, 2001). SIAs totaled 26 in Pakistan and 18 in 
Afghanistan in 2008 (CDC MMWR, 2009), 23 in Pakistan and 13 in Afghanistan in 2009 (CDC 
MMWR, 2010), and 20 in Pakistan and 12 in Afghanistan in 2010 (CDC MMWR, 2010). 
 Commonly cited barriers to vaccination coverage included active conflict, insecurity and 
weak managerial and operational coordination (CDC MMWR, 2013; CDC WER, 1999; CDC 
MMWR, 2008; CDC MMWR, 2009; CDC MMWR, 2010; CDC MMWR, 2011). Increased 
resources and political commitment were repeatedly called for (CDC MMWR, 2009; CDC 
MMWR, 2011; CDC MMWR, 2012). Surveillance was weak or completely lacking for acute 
flaccid paralysis (AFP) cases. Attacks on polio workers in December 2012 and early 2013 also 
stalled SIA activities in Pakistan until increased security precautions were taken for workers. 
However, accompaniment of polio workers by law enforcement has not had a positive influence 
on increasing community vaccine acceptance or reducing parent refusal (CDC MMWR, 2013). 
 
Measles 
 
Nine articles addressed measles in the EMR, including five in Somalia, three in Afghanistan, and 
one in Sudan. Most of these articles studied measles mortality on a refugee camp level. Mortality 
for children under five years of age was disproportionately high in all of these camps, and every 
study noted that measles, along with acute respiratory infections and diarrhea, was one of the 
main causes of death. Percentage of death attributed to measles ranged from 8% in Afghan 
refugee camps in 1984 (Boss, 1987) to over 60% in refugee camps in Somalia in the early 1980s 
(Toole, 1988). Vaccination coverage also was reported as very low in every study, with the 
highest coverage at 83.9% in Somali refugee camps in Kenya in 2011 after a vaccination 
campaign following an outbreak (Polonsky, 2013), whereas countrywide vaccination coverage 
within Somalia was reported as only 46% in 2010 and 2011. This two year interruption in 
vaccination coverage resulted in a massive measles outbreak, with cases increasing from 145 to 
1562 cases per million children under five years (Kebede, 2012). The need for persistent, high 
coverage of vaccination was also demonstrated in the study in Kenya, where the breakdown in 
registration and vaccination services resulted in a measles outbreak, spiking measles to account 
for 17% of under five mortality (Polonsky, 2013). In addition, several studies showed high 
resident mortalities from measles in addition to displaced and refugee populations (Moore, 1993; 
Gessner, 1993), demonstrating the negative effects of conflict and infectious disease not only on 
refugees and displaced people, but also residents of the countries. 
 Reasons for low coverage of measles vaccination included widespread fighting and 
insecurity, remote location of communities, stock-outs, rainy seasons, and mass population 
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movement (Boss, 1987; Toole, 1988; Assefa, 2001; CDC WER, 2004; Mirza, 2012). Many 
articles stated entire regions were inaccessible for vaccination due to conflict, such as the 
southern and central regions in Somalia in 2010 and 2011 (CDC MMWR, 2012) and western 
Darfur in Sudan in 2004 (CDC WER, 2004). A few articles recommended strengthening of 
community health programs to improve vaccination coverage, vitamin A delivery, and 
malnutrition (Moore, 1993; Assefa, 2001). Child Health Days in Somalia proved to be an 
effective approach, closing the gap between rural and urban populations and reaching 84% more 
infants than prior traditional EPI approaches (Mirza 2012). Outbreak response immunization 
(ORI) strategies were also implemented on a large scale in Kenya and Sudan. However, measles 
cases persisted after the ORI campaigns, emphasizing the need for thorough prevention over 
rapid response (CDC WER, 2004; Kebede, 2012). Several articles also called for improved 
surveillance in conflict settings in order to determine the most effective approaches and 
technologies for prevention and follow-up (Gessner, 1993; Toole, 1988; CDC WER, 2004). 
 
Tetanus, Diphtheria, and Pertussis 
 
Two articles addressed tetanus (Boss, et al., 1987; Mirza et al., 2012) and one additionally 
addressed diphtheria and pertussis (Mirza, et al., 2012). While improvements in child mortality 
were observed from 1984 to 1985 among Afghan refugees in Pakistan with a decrease from 
22.5% to 18.8% of children dying before their fifth birthday, neonatal tetanus increased in 
percentage of cause of death from 6 to 9%. However, differences were not statistically 
significant. The EPI’s goal by 1990 was less than one death from neonatal tetanus per 1000 live 
births, while this camp still had a level of 17 tetanus deaths per 1000 births (Boss et al., 2012). 
 The other study examined Somalia and its efforts with its child survival intervention of 
Child Health Days within an unstable country with poor infrastructure. Child Health Days were 
conducted every six months and were found to be successful in reducing urban and rural 
disparities as well as increasing third dose of DPT coverage from 31% in 2008, to 51% in 2009, 
to 66% in 2010. Security constraints in some regions proved to be the greatest obstacles to 
increased coverage, but CHDs overall provided increased coverage compared to the usual efforts 
of routine EPI services in Somalia’s fragmented healthcare system (Mirza, et al., 2012). 
 
Other vaccine-preventable diseases 
 
Only one result was found for hepatitis B, concerning Afghan refugees in Pakistan (Quddus, 
2006). Seroprevalence in children under five was 5.9% (95% CI: 2.4 – 11.9%; Quddus, 2006) 
compared to 2.4% prevalence in the general Pakistani pediatric population (Ali et al., 2009). In 
addition, HBsAg positive mothers were 7.15 times more likely to have HBsAg positive children. 
Hepatitis B vaccination was not included in the Balochistan camps at the time of the study, and 
the article highly recommended its inclusion as a routine immunization (Quddus, 2006). 
 No results were found studying Hib, rubella, tuberculosis, or yellow fever in children under 
five in conflict-affected EMR countries. Hib vaccine was only universally introduced into the 
EPI package by 2006, which may explain the lack of results, and yellow fever is only 
recommended in Somalia and Sudan (CDC, 2013). Tuberculosis typically affects older 
populations, explaining the lack of results for children under five years old. 
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Discussion
Countries and conflict timelines 
 
Afghanistan has been in a constant state of conflict since 1978, involving intrastate conflict with 
foreign involvement. Severe civil war, the Taliban movement, and US-led international 
intervention characterized the constant state of upheaval and insecurity (Uppsala, 2013). This 
history heavily influences Afghanistan’s weak health system and inability to eradicate polio. 
Also, extensive foreign involvement may explain the large number of results based in 
Afghanistan.  
 Pakistan has also experienced multiple interstate and intrastate conflicts since 1975. 
Pakistan has engaged in clashes with India, was involved in the War on Terror against al-Qaida, 
and has experienced many military coups and struggles over government power (Uppsala, 2013). 
Provincially localized conflicts have heavily influenced vaccination coverage and disease 
outbreaks, resulting in the high percentage of inaccessible populations reported in the CDC 
MMWRs.  
 Sudan also is characterized by constant conflict. Especially noteworthy was South Sudan’s 
fight for independence, which was won in 2011, followed by continued struggles over the 
establishment of the border. The Sudan People’s Liberation Movement/Army struggled with the 
government from 1983 to 2004, along with fighting in Darfur in 2003. Sudanese militias are 
infamous for human rights violations and large scale one-sided violence (Uppsala, 2013). Again, 
this persistent conflict through the decades explains historically low vaccination coverage, mass 
displacement of people, and outbreaks of disease. 
 Somalia’s armed conflict has been continuous since the early 1980s, when opposition 
groups attempted to overthrow President Barre. After his ousting in 1991, international troops 
became involved until 1995 and Somalia went through two decades of dysfunctional governance 
while also suffering from drought and famine (Uppsala, 2013). Mass displacements of people, 
lack of governance, pervasive conflict, and a fragmented health system in which 80% of Somalis 
lacked basic care have precipitated the crisis of high mortality from vaccine-preventable disease 
(Mirza, 2012). 
 
Strategies for moving forward 
 
Strategic interventions are needed to reach these inaccessible children for vaccination and 
prevent excess mortality associated with conflict. As shown throughout this systematic review, 
prevention of these diseases becomes extremely difficult in insecure settings, despite the 
effectiveness and cost-benefit of vaccination. Prevention can happen on many levels: primary 
prevention equates to conflict resolution and stopping the violence; secondary prevention 
involves contingency planning, surveillance, and personnel training; tertiary prevention means 
the prevention of excess mortality through mass vaccination campaigns and humanitarian relief 
(Toole & Waldman, 1997). Some recommendations for each level of prevention surfaced 
throughout many of the articles in this review. 
Interruption of poliovirus faces barriers posed by a disastrous mix of armed conflict, high 
population density, poor sanitation, low of vaccination coverage, and weak or absent health 
infrastructure (CDC MMWR, 2000). The Global Polio Eradication Initiative (GPEI) enacted a 
strategic plan in 2010 in order to stop transmission of wild poliovirus by 2012. This plan focuses 
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on targeted and planned approaches to address heterogeneity in OPV coverage and transmission 
(WHO GPEI, 2012). In 2011, GPEI stated that the world is not on track for its end of 2012 
global goal of ending all WPV transmission, or for any time soon after, without tackling 
fundamental problems of security, managerial, and resource issues (CDC MMWR, 2012). 
Pakistan was identified as the greatest overall risk to the GPEI in its 2011 meeting (CDC 
MMWR, 2011).  
 Emergency plans were constructed for Afghanistan and Pakistan. SIAs need to involve 
local leaders in planning and social mobilization, in order to focus on hard-to-reach areas, tailor 
improved training, and target house-to-house canvassing. In addition, improved accountability is 
needed in administrative leaders to improve supervision, monitoring, and performance of 
vaccination teams (CDC MMWR, 2012). Technical support and human resources are needed in 
polio-endemic countries in order to develop national capacity and expertise (CDC MMWR, 
2013). Better planning, coordination, and surveillance are critical to quash further polio 
transmission, and would operate on both the secondary and tertiary levels of prevention. 
 This mobilization of political commitment and resources could also help strengthen other 
immunization and preventive services, as demonstrated in other countries (CDC WER, 1999). 
Reaching high risk populations would help maintain a >95% measles vaccination coverage and 
ensure herd immunity, as well as disseminate other critical vaccines in the EPI package. Capacity 
for surveillance would grow, and awareness and utilization of routine services would increase. 
Better management and local stakeholder involvement would not only improve OPV 
implementation, but also build other basic health services. 
 “Days of tranquility” were also recommended in several of the articles of this search to 
help reach high risk areas in prolonged conflict and little central governance (CDC MMWR, 
2012; CDC MMWR, 2010). In order to execute this cease-fire intervention, negotiations with 
community and conflict leaders needs to be enhanced. These days of tranquility will help reach 
districts in Afghanistan and Pakistan with persistent polio transmission, as well as vaccinate 
chronically missed children for measles in Sudan and Somalia. This strategy was used effectively 
in El Salvador, lasting through the conflict from 1985 to 1992 and allowing 300,000 children to 
be immunized annually, incidence of measles and tetanus to drop dramatically, and polio to be 
eliminated (Krug, et al., 2002). 
 Vaccine diplomacy is another strategy that hints at primary prevention. As defined by 
Novotny and Adams, global health diplomacy is “a political change activity that meets the dual 
goals of improving global health while maintaining and strengthening international relations 
abroad, particularly in conflict areas and resource-poor environments” (2007). Vaccine 
diplomacy offers a potential opening for not only scientific collaboration but also an avenue of 
foreign policy negotiations. The strategy dates back to the Cold War, in which US and Soviet 
doctors partnered to develop the oral polio vaccine and improve the smallpox vaccine, leading to 
eventual worldwide eradication. This model could be applied to diseases included in this 
systematic review or other neglected tropical diseases, fostering collaboration and cooperation 
while also serving the interests of both actors. Political, structural, and social peace building 
would be fostered as public- and private- sector leaders negotiate opportunities for public health 
interventions (Katz et al., 2011). Joint scientific collaboration with countries in the EMR could 
lead to better international health and improved global security, as well as serve the health of the 
society and the economy of these countries (Hotez, 2010). 
 More strategic interventions are needed to effectively increase basic vaccination coverage 
and reduce excessive mortality in children under five associated with conflict in the EMR. 
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However, as evidenced in this review, the key element must be total political commitment and 
collaboration. 
 
Limitations 
 
The nature of this systematic review introduced several elements of bias. Publication bias must 
be acknowledged, as many countries with fewer academic institutions or less foreign 
involvement would have fewer papers published. Only four out of 18 conflict-affected countries 
in the EMR had articles that fit the study criteria, and those four each have significant 
humanitarian and foreign involvement. In addition, publication dates averaged to 2005, despite a 
wide inclusion window from 1974 to present. This was partially influenced by increasing 
publication rates in more recent years, as well as recent pushes to increase vaccination coverage 
by GVAP, UNICEF, GPEI, the MDGs, and others. The international pressure for polio 
eradication may explain its high proportion of articles (n= 17). In addition, universal coverage of 
some of the EPI vaccines was only reached recently, perhaps explaining the lack of results for 
Hib, tuberculosis, rubella, and yellow fever. 
 The results also cannot be considered perfectly reliable. Many numbers used in the 
MMWRs are state reported, and other data are collected in challenging, insecure environments. 
Many cases are missed due to the retrospective nature of the household surveys, based on recall 
bias and dependent on the presence of at least one adult per household, and cause of death is 
often misclassified due to the inexact nature of the interviews and assignment of symptoms. 
While these studies are often the only way to estimate the current situation, they do not offer a 
perfect assessment.  
 An important limitation to note is the restriction of this systematic review to published 
literature. Grey literature of interest was identified in the forward search but not included in 
analysis, only for relevant information in background and discussion. In addition, only articles in 
English were included in this review, potentially missing many articles published from within the 
EMR. 
 Finally, only a single reviewer screened the abstracts and full texts. In the future, a second 
reviewer is needed to help reduce selection bias of articles and ensure that criteria are as 
rigorously adhered to as possible. 
 
Future directions 
 
This systematic review clearly demonstrates a large gap in the literature concerning EPI 
vaccination coverage and need in the EMR. Many conflict-affected countries are not represented 
in this sample. Further research must be done to understand the impact of vaccine-preventable 
diseases in conflict-affected areas and the interventions that would be most effective in each 
context. 
 Beyond the EMR, this exercise would also be useful in conflict-affected countries around 
the world. Vaccination delivery mechanisms across different countries and contexts would also 
be interesting to examine. Cross-regional learning could help countries roll out vaccination 
interventions in times of insecurity more effectively.  
 
 
 
Adams 15 
Conclusions 
 
Conflict remains one of the greatest threats to public health, resulting in mass displacement of 
people, destruction of health infrastructure, and mass mortality by many easily preventable 
causes. In the Eastern Mediterranean Region, greater political commitment, surveillance, and 
operational capacity for national vaccination with the EPI package could result in a large number 
of lives saved in a cost-effective manner. Strategic approaches are needed to reach high risk 
populations and achieve polio eradication in these conflict-affected areas, as well as to prevent 
excess morbidity and mortality. 
 One of the most important results from this review is its emphasis on the need for 
improved documentation and evaluation of vaccination campaigns and vaccine preventable 
disease in conflict-affected areas. More efforts are needed to document the impact of these 
diseases in conflict areas, as well as evaluate effective intervention strategies, cost-effectiveness, 
and cost-benefits of different vaccines. As the EPI considers adding even more vaccinations to 
its basic package, it is important to understand the burden and necessity of their need in these 
emergency situations. 
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Appendix  
 
Table A1. Search terms included in initial database search ! !
Conflict-related terms EMR terms EPI Vaccine-related 
terms 
Child-related terms 
Refugees 
refugee*.tw 
(internal* adj1  
displace*).tw 
(displace* adj1  
person*).tw 
(conflict* adj1  
affected).tw 
(post* adj1  
conflict*).tw 
War     
(wars or warfare or  
wartime or  
terrorism).tw 
Afghanistan 
Bahrain 
Dijbouti  
Egypt 
Iran 
Iraq 
Jordan 
Kuwait 
Lebanon 
Libya 
Morocco 
Oman 
Pakistan 
Qatar 
Saudi Arabia 
Somalia 
Sudan 
Syria 
Tunisia 
United Arab Emirates 
Yemen 
 
Poliomyelitis 
Diphtheria 
Tuberculosis 
Whooping cough 
Measles 
Rubella 
Tetanus 
Haemophilus influenzae  
type b 
Hepatitis B 
BCG vaccine 
Yellow fever 
(polio* or pertussis or  
HepB or HiB or DTP or  
OPV).tw 
Child 
Infant 
Child*.tw 
 
Limited to English language. 
Limited to 1974 - present (EPI was established in 1974). 
!
Note: Terms separated by “OR” within columns; terms separated by “AND” between columns. 
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Table A3. Description of Final Results  !
Author 
(Year) Title 
Country of 
Population's 
Origin 
Country 
where study 
took place 
Disease 
studied Relevant findings 
Original articles from database search    
Assefa 
(2001) 
Malnutrition and mortality in 
Kohistan district, Afghanistan, 
April 2001 Afghanistan Afghanistan Measles 
In the midst of a long civil conflict, the 
crude mortality rate of children under 5 
years was 5.6 per 10,000 per day, with 
15.7% of deaths attributed to measles. 
Polio vaccine coverage was low at 73.7%. 
Boss 
(1987) 
Infant mortality and childhood 
nutritional status among 
Afghan refugees in Pakistan. Afghanistan Pakistan 
Measles, 
Tetanus 
From 1984 to 1985, the percentages of 
deaths <5 increased from 6 to 10% due to 
tetanus and 8 to 24% due to measles. 
However, overall percentage of death <5 
improved from 22.5 to 18.8%. 
Gessner 
(1994) 
Mortality rates, causes of death, 
and health status among 
displaced and resident 
populations of Kabul, 
Afghanistan Afghanistan Afghanistan Measles 
Highest mortality rates occurred in those 
<5 years who had been at their current 
location  <10 months. Measles as cause of 
death in both displaced and residents <5 
years were respectively 18% and 10%. 
MMWR 
(2001) 
Progress toward poliomyelitis 
and dracunculiasis eradication - 
Sudan, 1999-2000 Sudan Sudan Poliovirus 
AFP surveillance improved and the 
number of children <5 vaccinated 
increased due to NIDs and door-to-door 
campaigns. However, southern Sudan still 
has low OPV coverage of estimated 20%. 
MMWR 
(2009) 
Progress towards interruption 
of wild poliovirus transmission 
- Afghanistan and Pakistan, 
2008 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
Despite coordinated SIAs, polio incidence 
and the percentage of children <5 years 
living in inaccessible areas increased from 
2007 to 2008 in both countries. Security 
access remained the top barrier to 
vaccination access. 
MMWR 
(2009) 
Progress towards interruption 
of wild poliovirus transmission 
- worldwide, 2008 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
Afghanistan and Pakistan reported 31 and 
118 WPV cases, respectively, attributing 
most cases to conflict-affected regions and 
border areas with security problems. OPV3 
coverage was 83% and 44 SIAs occurred 
in both countries combined. 
MMWR 
(2010) 
Progress towards interruption 
of wild poliovirus transmission 
- worldwide, 2009 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
Afghanistan and Pakistan reported 38 and 
89 WPV cases, respectively, with 
difficulties continuing with accessing 
children in insecure areas. 
MMWR 
(2011) 
Progress Toward Poliomyelitis 
Eradication — Afghanistan and 
Pakistan, January 2010-
September 2011 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
WPV incidence increased in both 
Afghanistan and Pakistan during 2010-
2011, with cases occurring mainly in 
conflict-affected, inaccessible regions that 
are insecure for vaccination teams. 
Kebede 
(2012) 
Measles -  Horn of Africa, 
2010-2011 Somalia Somalia Measles 
Interruption of MCV services for 2 years 
due to conflict led to a massive measles 
outbreak, increasing from 145 to 1562 
cases per million  children <5 years. 
Refugees also transported measles to 
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neighboring Ethiopia and Kenya. 
MMWR 
(2012) 
Progress Toward Poliomyelitis 
Eradication — Afghanistan and 
Pakistan, January 2011-August 
2012 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
WPV incidence fell from 2011 to 2012, 
but remains endemic in inaccessible areas 
of both countries due to insecurity, where 
hundreds of thousands of children are still 
unvaccinated. 
MMWR 
(2013) 
Progress towards poliomyelitis 
eradication in Pakistan, January 
2012 - September 2013 Pakistan Pakistan Poliovirus 
The number of WPV cases decreased from 
54 to 52 from the same period a year prior. 
OPV3 coverage was 89% with a large 
range between provinces, due to security 
limitations, vaccination bans, and targeted 
attacks against polio workers. 
Naeem 
(2012) 
Coverage and causes of non 
immunization in National 
Immunization Days for polio; a 
consumer and provider 
perspective study in Peshawar. Pakistan Pakistan Poliovirus 
NIDs have been a partial success, with 
significant discrepancies between rural and 
urban and other sociodemographic factors. 
EPI staff also faces difficulties such as 
transport, lack of awareness, and security. 
Polonsky 
(2013) 
High levels of mortality, 
malnutrition, and measles, 
among recently-displaced 
Somali refugees in Dagahaley 
camp, Dadaab refugee camp 
complex, Kenya, 2011 Somalia Kenya Measles 
Due to breakdown in registration and 
vaccination approaches, a measles 
outbreak resulted in 17% of deaths, with 
an overall  <5 death rate of 1.8 per 10,000 
person-days in the camp. 
Quddus 
(2006) 
Prevalence of hepatitis B 
among Afghan refugees living 
in Balochistan, Pakistan Afghanistan Pakistan 
Hepatitis 
B 
Refugee mothers who were HBsAg 
positive  were much more likely to have an 
HBV infected child (OR = 7.15). Children 
<5 had a high prevalence of 5.9%. 
WER 
(1999) 
Progress toward poliomyelitis 
eradication, Afghanistan 1994-
1999 Afghanistan Afghanistan Poliovirus 
Coverage of OPVs in children <5 was 
estimated at 30% or lower for many 
regions, with most vaccination occurring 
during NIDs. Polio remained the leading 
cause of disability in Afghanistan.  
WER 
(2004) 
Prevention of measles deaths in 
Darfur, Sudan Sudan Sudan Measles 
Measles outbreaks ensued after conflict 
broke out with 711 cases and >10% case 
fatality rate. Mass vaccination campaigns 
had limited success; coverage was most 
restricted in high conflict Western Darfur 
and cases continued to occur. 
            
  
Articles from Forward Search         
Mirza 
(2012) 
Somalia: Supporting the Child 
Survival Agenda When Routine 
Health Service is Broken Somalia Somalia 
Diphtheria
, tetanus, 
pertussis, 
measles 
Child Health Days have effectively 
immunized 84% more infants with measles 
vaccination than routine EPI services and 
narrowed the gap between rural and urban 
coverage. 
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MMWR 
(2000) 
Progress toward poliomyelitis 
eradication - Eastern 
Mediterranean Region, 1999 - 
September 2000 
 Afghanistan, 
Pakistan, Sudan 
Afghanistan, 
Pakistan, 
Sudan  Poliovirus 
Compared with the same1999 period, 
confirmed cases in the EMR decreased by 
50%. Pakistan accounts for 60% of cases. 
Transmission interruption is expected in all 
but 4 countries by the end of the year. 
MMWR 
(2008) 
Progress toward poliomyelitis 
eradication - Afghanistan and 
Pakistan, 2007 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
Reduced to its lowest levels, WPV is still 
endemic to Afghanistan and Pakistan due 
to insecurity on the borders. OPV3 
coverage was 83% in Pakistan and 77% in 
Afghanistan with large regional variance. 
MMWR 
(2008) 
Progress toward interruption of 
wild poliovirus transmission - 
worldwide, January 2007 - 
April 2008 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
WPV1 cases decreased substantially in 
Afghanistan but not in Pakistan despite 
little change in WPV3 cases; transmission 
continues due to security and managerial 
issues on the border. 
MMWR 
(2010) 
Progress toward poliomyelitis 
eradication - Afghanistan and 
Pakistan, 2009 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
Coordinated SIAs continued, but were 
limited by security issues and population 
displacement. Up to 20% of children were 
inaccessible in both countries at certain 
times of the year. 
MMWR 
(2011) 
Progress toward interruption of 
wild poliovirus transmission - 
worldwide, January 2010 - 
March 2011 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
Afghanistan reported decreases in WPV 
cases from 2009 to 2010, but Pakistan 
reported significant increases despite 
conducting many SIAs. Increased political 
commitment and resources are needed. 
MMWR 
(2012) 
Progress toward interruption of 
wild poliovirus transmission - 
worldwide, January 2011 - 
March 2012 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
Despite large reductions in worldwide 
WPV incidence, substantial increases were 
reported in WPV cases for Afghanistan 
from 2010 to 2011, along with marginal 
increases in Pakistan. 
MMWR 
(2013) 
Progress toward eradication of 
polio - worldwide, January 
2011- March 2013 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan Poliovirus 
WPV cases decreased in both Afghanistan 
and Pakistan with OPV3 coverage of 66% 
and 75% respectively, with substantial in 
country variability. However, attacks on 
health workers threaten progress. 
Moore 
(1993) 
Mortality rates in displaced and 
resident populations of central 
Somalia during 1992 famine Somalia Somalia Measles 
In displaced persons camps, <5 mortality 
was estimated at 74% with primary causes 
of death as diarrhea and measles. 
Toole 
(1988) 
An analysis of mortality trends 
among refugee populations in 
Somalia, Sudan, and Thailand Somalia Somalia, Sudan Measles 
Mortality rates for children <5 in Somali 
and Sudanese refugee camps were 
extremely high, up to 5 times higher than 
non-refugee children in these countries. Up 
to 60% of <5 deaths in some camps were 
due to measles. 
 
 
 
Table A4. Data Extraction from Final Results by Vaccine-Preventable Disease  
 
Main EMR 
Country of 
Origin 
Main  
Country of 
Study Year 
Reported # 
of Cases 
Total 
Observations 
Overall <5 
Mortality 
Disease-
specific 
% of 
death 
Vaccination 
Coverage of 
Population 
Author 
(Pub 
Year) 
Type of 
Study 
Level of 
Population 
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POLIOVIRUS 
                    
Afghanistan Afghanistan 
1994-
1999 
19 in Sept-
Dec 1997; 59 
in 1998; 43 
in Jan-Aug 
1999 N/A N/A N/A 
<30% (3 
doses) in 
1996; ~80% 
(2 doses) in 
1997 
WER 
(1999) 
Progress 
update Countrywide 
Afghanistan, 
Pakistan, 
Sudan 
Afghanistan, 
Pakistan, 
Sudan 
1999 - 
Sept 
2000 
63 in 
Afghanistan; 
324 in 
Pakistan; 10 
in Sudan in 
1999 N/A N/A N/A 
32% in 
Afghanistan; 
80% in 
Pakistan, 77% 
in Sudan 
MMWR 
(2000) 
Progress 
update EMR-wide 
Sudan Sudan 
1999-
2000 
10 in 1999; 4 
in 2000 N/A N/A N/A 
90% in 1999; 
70% in 2000 
(3 doses to <5 
years) 
MMWR 
(2001) 
Progress 
update Countrywide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 
Jan 
2007 - 
Apr 
2008 
17 in 2007 
and 5 in Jan-
Apr 2008 in 
Afghanistan; 
32 in 2007 
and 4 in Jan-
Apr 2008 in 
Pakistan N/A N/A N/A 
77% in 
Afghanistan; 
83% in 
Pakistan (3 
doses in <1 
years) 
MMWR 
(2008) 
Progress 
update Worldwide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 2007 
17 in 
Afghanistan; 
32 in 
Pakistan N/A N/A N/A 
77% in 
Afghanistan; 
83% in 
Pakistan (3 
doses in <1 
years) 
MMWR 
(2008) 
Progress 
update Countrywide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 2008 
31 in 
Afghanistan; 
118 in 
Pakistan N/A N/A N/A 
83% in both 
(3 doses in <1 
years) 
MMWR 
(2009) 
Progress 
update Countrywide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 2008 
31 in 
Afghanistan; 
118 in 
Pakistan N/A N/A N/A 
83% in both 
(3 doses in <1 
years) 
MMWR 
(2009) 
Progress 
update Worldwide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 2009 
38 in 
Afghanistan; 
89 in 
Pakistan N/A N/A N/A 
84% in EMR 
(3 doses in <1 
years) 
MMWR 
(2010) 
Progress 
update Worldwide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 2009 
38 in 
Afghanistan; 
89 in 
Pakistan N/A N/A N/A 
85% in 
Afghanistan; 
81% in 
Pakistan (3 
doses in <1 
years) 
MMWR 
(2010) 
Progress 
update Countrywide 
Pakistan Pakistan 2010 N/A 
600 households 
with children 
<5 N/A N/A 
83.7% (3 
doses) 
Naeem 
(2012) 
Cross-
sectional 
household 
survey Province level 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 
Jan 
2010 - 
Mar 
2011 
25 in 2010 
and 1 in Jan-
Mar 2011 in 
Afghanistan; 
144 in 2010 
and 26 in 
Jan-Mar 
2011 in 
Pakistan N/A N/A N/A 
86% in EMR 
(3 doses in <1 
years) 
MMWR 
(2011) 
Progress 
update Worldwide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 
Jan 
2010 - 
Sept 
2011 
25 in 2010 
and 42 in 
Jan-Sept 
2011 in 
Afghanistan; 
144 in 2010 N/A N/A N/A 
66% in 
Afghanistan; 
88% in 
Pakistan (3 
doses in <1 
years) 
MMWR 
(2011) 
Progress 
update Countrywide 
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and 120 in 
Jan-Sept 
2011 in 
Pakistan 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 
Jan 
2011 - 
Mar 
2012 
80 in 2011 
and 6 in Jan-
Mar 2012 in 
Afghanistan; 
198 in 2011 
and 15 in 
Jan-Mar 
2012 in 
Pakistan N/A N/A N/A N/A 
MMWR 
(2012) 
Progress 
update Worldwide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 
Jan 
2011 - 
Aug 
2012 
80 in 2011 
and 17 in 
Jan-Aug 
2012 in 
Afghanistan; 
198 in 2011 
and 30 in 
Jan-Aug 
2012 in 
Pakistan N/A N/A N/A 
66% in 
Afghanistan; 
75% in 
Pakistan (3 
doses in <1 
years) 
MMWR 
(2012) 
Progress 
update Countrywide 
Pakistan Pakistan 
Jan 
2012 - 
Sept 
2013 
58 in 2012; 
52 in Jan-
Sept 2013 N/A N/A N/A 
89% (3 doses 
in <1 years) 
MMWR 
(2013) 
Progress 
update Countrywide 
Afghanistan, 
Pakistan 
Afghanistan, 
Pakistan 
Jan 
2011 - 
Mar 
2013 
37 in 2012 in 
Afghanistan; 
58 in 2012 in 
Pakistan N/A N/A N/A 
66% in 
Afghanistan; 
75% in 
Pakistan (3 
doses in <1 
years) 
MMWR 
(2013) 
Progress 
update Worldwide 
 
 
 
 
 
MEASLES     
  
               
Afghanistan Pakistan 
1984-
1985 
10 in 1984; 
27 in 1985 
1512 
households in 
1984; 1566 
households in 
1985 
225 per 1000 
in 1984; 188 
per 1000 in 
1985 
8% of 
deaths in 
1984; 24% 
in 1985 N/A 
Boss 
(1987) 
Systematic 
household 
survey 
Refugee 
camps 
Somalia 
Somalia, 
Sudan 
1980-
1985 N/A 
3 camps in 
Somalia; 3 
camps in Sudan 
28 per 10,000 
per day in 
Somalia; 22.2-
32.6 per 
10,000 per 
day in Sudan 
60% in 
Somalia; 
most 
common 
cause in 
Sudan 
78% in 
Somalia 
Toole 
(1988) 
Cluster 
household 
survey 
Refugee 
camps 
Somalia Somalia 1992 
33 in Baidoa; 
39 in Afgoi 
62 children in 
Baidoa; 211 in 
Bagoi 
32 per 10,000 
per day in 
Baidoa; 10.4 
per 10,000 per 
day in Afgoi 
25% in 
Baidoa, 
34% in 
Afgoi N/A 
Moore 
(1993) 
Cluster 
household 
survey 
Refugee 
camps, 
residents 
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Afghanistan Afghanistan 1993 
9 displaced 
cases; 10 
resident 
cases 
312 displaced 
families; 300 
resident 
families 
1.9 per 10,000 
person-day 
displaced; 1.1 
per 10,000 
person-day 
resident 
18% in 
displaced; 
10% in 
resident 
74% of 
displaced; 
78% of 
resident 
Gessner 
(1993) 
Cross-
sectional 
household 
survey City level 
Afghanistan Afghanistan 2001 14 deaths 763 children 5.9 per 10,000 23.70% N/A 
Assefa 
(2001) 
Cluster 
household 
survey District level 
Sudan Sudan 
March-
June 
2004 711 cases N/A N/A 
10% Case 
fatality rate 77% 
WER 
(2004) 
Outbreak 
investigation 
Refugee 
camps 
Somalia Somalia 
2009-
2010 N/A 
909,690 in 
2009; 
1,241,590 in 
2010 
180 per 1000 
live births N/A 
84% of 
regions with 
>50% routine 
measles 
coverage 
Mirza 
(2012) 
Intervention 
evaluation Countrywide 
Somalia Somalia 
2010-
2011 
976 in 2010; 
11,601 in 
2011 N/A N/A N/A 
46% in 2010 
& 2011 
Kebede 
(2012) 
Progress 
update Countrywide 
Somalia Kenya 2011 619 cases 
6488 children 
<5 years 
1.8 per 10,000 
person-days 17% 83.90% 
Polonsky 
(2013) 
Systematic 
household 
survey Refugee camp 
HEPATITIS B                   
Afghanistan Pakistan  2003 7 119 N/A N/A 1% 
Quddus 
(2006) 
Cross-
sectional 
household 
survey 
Refugee 
camps 
 
TETANUS (Vaccination is DPT: Diphtheria, Pertussis, Tetanus)           
Afghanistan Pakistan 
1984-
1985 
8 in 1984; 11 
in 1985 
1512 
households in 
1984; 1566 
households in 
1985 
225 per 
1000 in 
1984; 188 
per 1000 in 
1985 
22% of 
neonatal 
deaths in 
1984; 38% 
in 1985 N/A 
Boss 
(1987) 
Systematic 
household 
survey 
Refugee 
camps 
Somalia Somalia 
2009-
2010 N/A 
36,460 in 2009; 
53567 in 2010 
180 per 
1000 live 
births N/A 
51% in 2009; 
66% in 2010 
Mirza 
(2012) 
Intervention 
evaluation Countrywide !
